Back to top
more

Loncar China BioPharma ETF: (CHNA)

(Delayed Data from NASDAQ) As of Jan 16, 2020 03:48 PM ET

 Add to portfolio

$26.25 USD

26.25
6,355

+0.79 (0.79%)

Volume: 6,355

Zacks ETF Rank NA

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Quote Details

Previous Close 25.46
Open 25.78
Bid 26.08
Ask 26.39
Day Low-High 25.78-26.27
52wk Low-High 19.66-26.27
Volume 6,355
NAV (month end) 24.64
Premium (+)/Discount (-) (month end)+0.82

Zacks Premium Research for CHNA

Zacks ETF Rank NA
ETF Risk NA
ETF Research Report

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Expense Ratio

Expense Ratio 0.79%
Dividend (Yield) $0.04 (0.15%)
Issuer LONCAR INVESTMENTS

Benchmark for CHNA

LONCAR CHINA BIOPHARMA INDEX

The Loncar China BioPharma Index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of pharmaceutical and biotech related industries from China.

Fund Summary for CHNA

LONCAR CHINA BIOPHARMA ETF

The Loncar China BioPharma ETF seeks to track the performance, before fees and expenses, of the Loncar China BioPharma Index.